Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway. | Mol Oncol | 2024 | 37753740 | PubTator, text mining | PubMed |
| GRPa-PRS: A risk stratification method to identify genetically-regulated pathways in polygenic diseases. | medRxiv | 2024 | 37425929 | PubTator, text mining | PubMed |
| Phage predation, disease severity and pathogen genetic diversity in cholera patients. | bioRxiv | 2024 | 37398242 | PubTator, text mining | PubMed |
| Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer. | Front Immunol | 2023 | 38235137 | PubTator, text mining | PubMed |
| Ferroptosis Inducers Upregulate PD-L1 in Recurrent Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 | 38201582 | PubTator, text mining | PubMed |
| Sporadic phage defense in epidemic Vibrio cholerae mediated by the toxin-antitoxin system DarTG is countered by a phage-encoded antitoxin mimic. | bioRxiv | 2023 | 38168179 | PubTator, text mining | PubMed |
| Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance-a bioinformatics analysis. | Transl Cancer Res | 2023 | 38130302 | PubTator, text mining | PubMed |
| Deep learning and transfer learning identify breast cancer survival subtypes from single-cell imaging data. | Commun Med (Lond) | 2023 | 38114659 | PubTator, text mining | PubMed |
| Insight into the mechanism of gallstone disease by proteomic and metaproteomic characterization of human bile. | Front Microbiol | 2023 | 38111640 | PubTator, text mining | PubMed |
| Identification of a core EMT signature that separates basal-like breast cancers into partial- and post-EMT subtypes. | Front Oncol | 2023 | 38111531 | PubTator, text mining | PubMed |
| The diagnostic yield of exome sequencing in liver diseases from a curated gene panel. | Sci Rep | 2023 | 38057357 | PubTator, text mining | PubMed |
| Genetic and clinical landscape of ER + /PR- breast cancer in China. | BMC Cancer | 2023 | 38049758 | PubTator, text mining | PubMed |
| Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways. | Sci Rep | 2023 | 38036593 | PubTator, text mining | PubMed |
| The potential role of gut microbiota outer membrane vesicles in colorectal cancer. | Front Microbiol | 2023 | 38029123 | PubTator, text mining | PubMed |
| A Rare Case of Progressive Familial Intrahepatic Cholestasis Type 4: A Case Report and Literature Review. | Cureus | 2023 | 38021987 | PubTator, text mining | PubMed |
| RSK3 switches cell fate: from stress-induced senescence to malignant progression. | J Exp Clin Cancer Res | 2023 | 38008756 | PubTator, text mining | PubMed |
| Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers. | Int J Mol Sci | 2023 | 38003261 | PubTator, text mining | PubMed |
| The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel USP53 Splicing Variants by Next Generation Sequencing. | Yonsei Med J | 2023 | 37992747 | PubTator, text mining | PubMed |
| Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis. | Nat Commun | 2023 | 37990006 | PubTator, text mining | PubMed |
| Activation and substrate specificity of the human P4-ATPase ATP8B1. | Nat Commun | 2023 | 37980352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=7